Fang Xu

机构：Luye Pharma (China) · ORCID：0000-0002-6731-1116

发表论文 57 篇 · 总被引 2036 次 · h-index 18

代表论文

Resveratrol Alleviates Dextran Sulfate Sodium-Induced Acute Ulcerative Colitis in Mice by Mediating PI3K/Akt/VEGFA Pathway (2021 · Frontiers in Pharmacology · 被引 53)
A clinical study of peripherally inserted central catheter-related venous thromboembolism in patients with hematological malignancies (2022 · Scientific Reports · 被引 24)
POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter Analysis (2021 · Clinical Lymphoma Myeloma & Leukemia · 被引 21)
Predictors of early death and clinical features in newly diagnosed patients with low-intermediate risk acute promyelocytic leukemia (2022 · Frontiers in Oncology · 被引 8)
Effects of peripheral blood leukocyte count and tumor necrosis factor-alpha on early death in acute promyelocytic leukemia (2023 · BMC Cancer · 被引 7)
Immune microenvironment regulation and clinical immunotherapy strategies of metastatic liver cancer (2025 · Frontiers in Immunology · 被引 5)